Rukiyah Van Dross

1.1k total citations
25 papers, 822 citations indexed

About

Rukiyah Van Dross is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Rukiyah Van Dross has authored 25 papers receiving a total of 822 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 13 papers in Pharmacology and 5 papers in Oncology. Recurrent topics in Rukiyah Van Dross's work include Cannabis and Cannabinoid Research (7 papers), Endoplasmic Reticulum Stress and Disease (4 papers) and Inflammatory mediators and NSAID effects (4 papers). Rukiyah Van Dross is often cited by papers focused on Cannabis and Cannabinoid Research (7 papers), Endoplasmic Reticulum Stress and Disease (4 papers) and Inflammatory mediators and NSAID effects (4 papers). Rukiyah Van Dross collaborates with scholars based in United States, Egypt and Grenada. Rukiyah Van Dross's co-authors include Eman Soliman, Jill C. Pelling, Xiaoman Hong, Adnan O. Abu‐Yousif, Daniel A. Ladin, Audrey Jenkins, Xin Tong, Aubrey R. Morrison, LaToya M. Griffin and Allison S. Danell and has published in prestigious journals such as Molecular and Cellular Biology, JNCI Journal of the National Cancer Institute and Cancer Research.

In The Last Decade

Rukiyah Van Dross

24 papers receiving 807 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rukiyah Van Dross United States 17 404 320 111 91 82 25 822
Hiroomi Tamura Japan 19 165 0.4× 493 1.5× 118 1.1× 90 1.0× 23 0.3× 83 1.1k
Chieh‐Hsi Wu Taiwan 21 190 0.5× 511 1.6× 192 1.7× 60 0.7× 28 0.3× 41 1.2k
James Truax United States 13 277 0.7× 384 1.2× 225 2.0× 36 0.4× 39 0.5× 25 1.2k
Beatrice Polini Italy 18 104 0.3× 379 1.2× 58 0.5× 55 0.6× 30 0.4× 51 911
Kyoo-Seok Ahn South Korea 20 158 0.4× 430 1.3× 114 1.0× 91 1.0× 56 0.7× 36 1.0k
Rosanna Avola Italy 17 84 0.2× 289 0.9× 107 1.0× 28 0.3× 44 0.5× 35 752
Sandra S. Mizokami Brazil 18 95 0.2× 346 1.1× 145 1.3× 42 0.5× 33 0.4× 24 933
Eman Soliman Egypt 17 259 0.6× 244 0.8× 63 0.6× 53 0.6× 16 0.2× 45 764
Xiang Han South Korea 21 231 0.6× 765 2.4× 287 2.6× 41 0.5× 14 0.2× 60 1.4k
Joe Eun Son South Korea 21 89 0.2× 447 1.4× 82 0.7× 72 0.8× 55 0.7× 35 1.2k

Countries citing papers authored by Rukiyah Van Dross

Since Specialization
Citations

This map shows the geographic impact of Rukiyah Van Dross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rukiyah Van Dross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rukiyah Van Dross more than expected).

Fields of papers citing papers by Rukiyah Van Dross

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rukiyah Van Dross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rukiyah Van Dross. The network helps show where Rukiyah Van Dross may publish in the future.

Co-authorship network of co-authors of Rukiyah Van Dross

This figure shows the co-authorship network connecting the top 25 collaborators of Rukiyah Van Dross. A scholar is included among the top collaborators of Rukiyah Van Dross based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rukiyah Van Dross. Rukiyah Van Dross is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dross, Rukiyah Van, et al.. (2022). Kinin B1R Activation Induces Endoplasmic Reticulum Stress in Primary Hypothalamic Neurons. Frontiers in Pharmacology. 13. 841068–841068. 5 indexed citations
2.
Elhassanny, Ahmed E. M., Eman Soliman, Mona A. Marie, et al.. (2020). Heme-Dependent ER Stress Apoptosis: A Mechanism for the Selective Toxicity of the Dihydroartemisinin, NSC735847, in Colorectal Cancer Cells. Frontiers in Oncology. 10. 965–965. 21 indexed citations
3.
Elhassanny, Ahmed E. M., Daniel A. Ladin, Eman Soliman, et al.. (2019). Prostaglandin D2-ethanolamide induces skin cancer apoptosis by suppressing the activity of cellular antioxidants. Prostaglandins & Other Lipid Mediators. 142. 9–23. 16 indexed citations
4.
Ladin, Daniel A., Eman Soliman, Timothy L. Fitzgerald, et al.. (2017). Synthesis and Evaluation of the Novel Prostamide, 15-Deoxy, Δ12,14-Prostamide J2, as a Selective Antitumor Therapeutic. Molecular Cancer Therapeutics. 16(5). 838–849. 15 indexed citations
5.
Soderstrom, Ken, Eman Soliman, & Rukiyah Van Dross. (2017). Cannabinoids Modulate Neuronal Activity and Cancer by CB1 and CB2 Receptor-Independent Mechanisms. Frontiers in Pharmacology. 8. 720–720. 36 indexed citations
6.
Ladin, Daniel A., Eman Soliman, LaToya M. Griffin, & Rukiyah Van Dross. (2016). Preclinical and Clinical Assessment of Cannabinoids as Anti-Cancer Agents. Frontiers in Pharmacology. 7. 361–361. 71 indexed citations
9.
Soliman, Eman, et al.. (2015). Apigenin inhibits COX-2, PGE2, and EP1 and also initiates terminal differentiation in the epidermis of tumor bearing mice. Prostaglandins Leukotrienes and Essential Fatty Acids. 104. 44–53. 45 indexed citations
10.
Dross, Rukiyah Van, et al.. (2012). Receptor-dependent and receptor-independent endocannabinoid signaling: A therapeutic target for regulation of cancer growth. Life Sciences. 92(8-9). 463–466. 24 indexed citations
11.
12.
Dross, Rukiyah Van. (2009). Metabolism of anandamide by COX‐2 is necessary for endocannabinoid‐induced cell death in tumorigenic keratinocytes. Molecular Carcinogenesis. 48(8). 724–732. 44 indexed citations
13.
Abu‐Yousif, Adnan O., Kimberly A. Smith, Spiro Getsios, et al.. (2008). Enhancement of UVB-Induced Apoptosis by Apigenin in Human Keratinocytes and Organotypic Keratinocyte Cultures. Cancer Research. 68(8). 3057–3065. 52 indexed citations
14.
Tong, Xin, Rukiyah Van Dross, Adnan O. Abu‐Yousif, Aubrey R. Morrison, & Jill C. Pelling. (2006). Apigenin Prevents UVB-Induced Cyclooxygenase 2 Expression: Coupled mRNA Stabilization and Translational Inhibition. Molecular and Cellular Biology. 27(1). 283–296. 102 indexed citations
15.
Dross, Rukiyah Van, et al.. (2006). Modulation of UVB‐induced and basal cyclooxygenase‐2 (COX‐2) expression by apigenin in mouse keratinocytes: Role of USF transcription factors. Molecular Carcinogenesis. 46(4). 303–314. 51 indexed citations
16.
Dross, Rukiyah Van, Philip J. Browning, & Jill C. Pelling. (2006). Do Truncated Cyclins Contribute to Aberrant Cyclin Expression in Cancer?. Cell Cycle. 5(5). 472–477. 14 indexed citations
17.
Dross, Rukiyah Van, Shan Yao, Deborah J. Mays, et al.. (2005). Constitutively Active K-cyclin/cdk6 Kinase in Kaposi Sarcoma–Associated Herpesvirus–Infected Cells. JNCI Journal of the National Cancer Institute. 97(9). 656–666. 31 indexed citations
18.
Dross, Rukiyah Van, Xiaoman Hong, & Jill C. Pelling. (2005). Inhibition of TPA‐induced cyclooxygenase‐2 (COX‐2) expression by apigenin through downregulation of Akt signal transduction in human keratinocytes. Molecular Carcinogenesis. 44(2). 83–91. 59 indexed citations
19.
Dross, Rukiyah Van, et al.. (2003). The Chemopreventive Bioflavonoid Apigenin Modulates Signal Transduction Pathways in Keratinocyte and Colon Carcinoma Cell Lines. Journal of Nutrition. 133(11). 3800S–3804S. 67 indexed citations
20.
Dross, Rukiyah Van, et al.. (1997). Cloning and characterization of the Aspergillus nidulans DNA topoisomerase I gene. Gene. 203(2). 169–174. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026